Zeiss MyoCare Lenses
-
Slows myopia progression in children with lenses designed for different age groups.
-
C.A.R.E.® and ClearFocus designs provide precise correction and control for all gaze directions.
-
Backed by decades of research and data, with 98% of kids reporting excellent vision.
-
Full UV protection, clear vision from all angles, and quick adaptability.
How does Myocare lenses work?
ZEISS supports children in managing rapid myopia progression with its advanced ZEISS MyoCare lenses, which are designed to be more effective than existing options.
With over 20 years of global clinical research and innovation, ZEISS incorporates cutting-edge science in myopia management, featuring two key pillars: C.A.R.E.® technology on the front surface of the lens and ClearFocus Design on the back surface.
C.A.R.E.® technology consists of two main zones: the central zone and the functional zone, each with its own role. The central zone ensures clear vision for children, while the functional zone contains refractive elements designed to slow the progression of myopia. These crucial components extend to the edge of the lens, sending a "stop signal" that reduces eye elongation, ultimately preventing myopia from worsening.
ZEISS MyoCare lenses incorporate cylindrical annular refractive elements in their design. They also feature a Clear Zone that ensures clear and sharp vision when looking straight ahead.
The peripheral functional zone is composed of annular cylinders, evenly distributed across the lenses with precise width, height, and spacing.
Light bundles passing through the C.A.R.E. elements of the ZEISS MyoCare lens are refracted to form a caustic area with an extended focus range that converges to a minimal point before diverging again. The functional zone creates alternating areas of simultaneous blur and myopic correction on the peripheral retina, designed to slow down myopia progression.
Proven Efficiency
The ZEISS MyoCare designs show an average emmetropic progression ratio for axial length of up to 86% for children aged 10–12 years and 63% for children aged 7–9 years.
